Oxford BioMedica PLC
LSE:OXB
Oxford BioMedica PLC
LSE:OXB
Price:
328 GBX
9.33%
Market Closed
Updated:
May 6, 2024
Oxford BioMedica PLC
Cash from Operating Activities
|
Oxford BioMedica PLC
Cash from Operating Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oxford BioMedica PLC
LSE:OXB
|
Cash from Operating Activities
£6.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Operating Activities
-$160.3m
|
CAGR 3-Years
-147%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Operating Activities
-$145.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Operating Activities
-$60.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Operating Activities
£2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Operating Activities
£44.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
See Also
What is Oxford BioMedica PLC's Cash from Operating Activities?
Cash from Operating Activities
6.5m
GBP
6.5m
GBP
Based on the financial report for Jun 30, 2023, Oxford BioMedica PLC's Cash from Operating Activities amounts to 6.5m GBP.
What is Oxford BioMedica PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-22%
-22%
You don't have any saved screeners yet
